<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-10</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-10</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>59</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>4</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
ç ”ç©¶æ­ç¤ºäº†SOAT1ä½œä¸ºç™Œç»†èƒå¹²ç»†èƒå…ç–«æ£€æŸ¥ç‚¹ï¼Œé€šè¿‡20(S)-ç¾ŸåŸºèƒ†å›ºé†‡-GPR132é€šè·¯æŠ‘åˆ¶è°ƒèŠ‚æ€§Tç»†èƒåŠŸèƒ½ï¼Œä¸ºç™Œç—‡å…ç–«æ²»ç–—æä¾›æ–°é¶ç‚¹ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚¿ç˜¤å…ç–«ä¸ç»†èƒé€šè®¯</strong>ï¼šæ¢ç©¶ç´«å¤–çº¿æš´éœ²åè¡€ç®¡ç»†èƒåœ¨ç‚ç—‡ååº”ä¸­çš„ä½œç”¨ï¼Œä»¥åŠSOAT1åœ¨ç™Œç—‡å…ç–«æŠ‘åˆ¶ä¸­çš„æœºåˆ¶ã€‚<br />
*   <strong>ç»†èƒåˆ†åŒ–ä¸å‘è‚²</strong>ï¼šè§£ææ—©æœŸå¿ƒè„è°±ç³»ç»†èƒåˆ†åŒ–è¿‡ç¨‹ä¸­çš„è¡¨è§‚é—ä¼ è°ƒæ§ï¼Œä»¥åŠå¤§è„‘ç±»å™¨å®˜å¯¹ä¸åŒåˆºæ¿€çš„æ€§åˆ«ç‰¹å¼‚æ€§å“åº”ã€‚<br />
*   <strong>ä»£è°¢è°ƒæ§ä¸ç–¾ç—…</strong>ï¼šInvestigating the metabolic features of senescent cells induced by cancer therapyï¼Œä»¥åŠé…®ç—‡é…¸æ€§é¥®é£Ÿå¯¹ç™½è¡€ç—…å’Œç»„è›‹ç™½ä¿®é¥°çš„å½±å“ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å¤šæ¨¡æ€ç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆå•ç»†èƒè½¬å½•ç»„å­¦ã€ç©ºé—´è½¬å½•ç»„å­¦ã€ATAC-seqã€ChIP-seqç­‰å¤šæŠ€æœ¯æ‰‹æ®µï¼Œæ·±å…¥è§£æç”Ÿç‰©å­¦è¿‡ç¨‹ã€‚<br />
*   <strong>æ–°å‹åˆ†æå¹³å°</strong>ï¼šåˆ©ç”¨é•¿è¯»é•¿æµ‹åºæŠ€æœ¯ï¼ˆNanoporeï¼‰åˆ†ææ— ç»†èƒè½¬å½•ç»„ï¼Œä¸ºç–¾ç—…æ—©æœŸè¯Šæ–­æä¾›æ–°æ€è·¯ã€‚</p>
<h3>ğŸ”¬ æœŸåˆŠæ–‡ç« </h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
é¦–æ¬¡éšæœºå¯¹æ¯”å¡æ‰˜å¸ƒé²æ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼åœ¨åˆæ²»åŠå¤å‘/éš¾æ²»æ€§æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤æ‚£è€…ä¸­çš„ç–—æ•ˆã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- è¯„ä¼° MET æ‰©å¢é©±åŠ¨çš„æ™šæœŸéå°ç»†èƒè‚ºç™Œæ‚£è€…å¯¹ Vebreltinib çš„æ²»ç–—ååº”ã€‚<br />
- åˆ†æ 2020-2023 å¹´ç¾å›½åŠ³åŠ¨å¹´é¾„æˆå¹´äººæŒ‰èŒä¸šåˆ’åˆ†çš„ç™Œç—‡æ­»äº¡ç‡å˜åŒ–è¶‹åŠ¿ã€‚<br />
- æ¢è®¨é¢„é˜²èŒä¸šæ€§ç™Œç—‡çš„é‡è¦æ€§ã€‚<br />
- æ¯”è¾ƒå¡æ‰˜å¸ƒé²æ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼æ²»ç–—åˆæ²»åŠå¤å‘/éš¾æ²»æ€§æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤çš„æœ‰æ•ˆæ€§å’Œå®‰å…¨æ€§ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- é‡‡ç”¨å¤šä¸­å¿ƒã€äºŒæœŸä¸´åºŠç ”ç©¶è®¾è®¡è¯„ä¼°æ–°å‹é¶å‘è¯ç‰© Vebreltinibã€‚<br />
- åŸºäºäººå£çš„å¤§è§„æ¨¡æ­»äº¡ç‡æ•°æ®åˆ†æï¼Œç²¾ç»†åˆ’åˆ†èŒä¸šå’Œç™Œç—‡ç±»å‹ã€‚<br />
- é¦–æ¬¡è¿›è¡Œå¡æ‰˜å¸ƒé²æ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼çš„å¤´å¯¹å¤´éšæœºå¯¹ç…§è¯•éªŒã€‚</p>
<h3>ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
freeCount R Shiny ç”Ÿç‰©ä¿¡æ¯åˆ†æåº”ç”¨ç°å·²é€šè¿‡ Posit Cloud æä¾›ï¼Œç”¨æˆ·æ— éœ€å®‰è£…å³å¯åœ¨çº¿è®¿é—®ï¼Œæå¤§é™ä½äº†ä½¿ç”¨é—¨æ§›ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>åœ¨çº¿ç”Ÿç‰©ä¿¡æ¯åˆ†æ</strong>ï¼šåˆ©ç”¨ Posit Cloud å¹³å°ï¼Œç›´æ¥åœ¨æµè§ˆå™¨ä¸­è¿›è¡Œ freeCount R Shiny åº”ç”¨çš„ç”Ÿä¿¡åˆ†æã€‚<br />
*   <strong>ç®€åŒ–æ•°æ®ç§‘å­¦å·¥å…·è®¿é—®</strong>ï¼šæä¾›æ— éœ€æœ¬åœ°å®‰è£…çš„å¼ºå¤§æ•°æ®ç§‘å­¦å·¥å…·ï¼Œä¿ƒè¿›ç”Ÿç‰©ä¿¡æ¯å­¦ç ”ç©¶çš„å¯åŠæ€§ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>åŸºäºäº‘çš„ R Shiny åº”ç”¨</strong>ï¼šé€šè¿‡ Posit Cloud éƒ¨ç½² R Shiny åº”ç”¨ï¼Œå®ç°è·¨å¹³å°ã€æ— å®‰è£…çš„ä¾¿æ·ä½¿ç”¨ä½“éªŒã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
è‚ é“å¾®ç”Ÿç‰©ä»£è°¢ç‰©TMAè¢«å‘ç°å¯ç›´æ¥é˜»æ–­IRAK4ï¼Œæœ‰æ•ˆé™ä½ç‚ç—‡å¹¶æ”¹å–„èƒ°å²›ç´ æ•æ„Ÿæ€§ï¼Œé¢„ç¤ºç€æ²»ç–—ç³–å°¿ç—…çš„æ–°é€”å¾„ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- ç³–å°¿ç—…æ²»ç–—ï¼šé€šè¿‡é¶å‘è‚ é“å¾®ç”Ÿç‰©ä»£è°¢ç‰©TMAä¸IRAK4ç›¸äº’ä½œç”¨ï¼Œæ”¹å–„èƒ°å²›ç´ æŠµæŠ—ã€‚<br />
- å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰æ•°æ®åˆ†æï¼šæé«˜å¯¹è½¬å½•æœ¬å˜å¼‚çš„è§£è¯»å‡†ç¡®æ€§ï¼ŒåŒºåˆ†æŠ€æœ¯æ€§é›¶å€¼ä¸ç”Ÿç‰©å­¦ä¿¡å·ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- Isoformicï¼šæ–°å‹å·¥ä½œæµç¨‹ï¼Œå®ç°è½¬å½•æœ¬å±‚é¢çš„RNA-seqæ•°æ®è§£è¯»ï¼Œå…³è”ç”Ÿç‰©å­¦å˜å¼‚ä¸è°ƒæ§äº‹ä»¶ã€‚<br />
- D3Imputeï¼šåŸºäºåŒºåˆ†æ€§ã€åˆ†å¸ƒæ„ŸçŸ¥å’Œå¯†åº¦å¼•å¯¼çš„ imputation æ–¹æ³•ï¼Œæ˜¾è‘—æå‡scRNA-seqæ•°æ®åˆ†æçš„ç²¾ç¡®åº¦ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (51æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE298107 å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºç´«å¤–çº¿ç…§å°„åè¡€ç®¡ç»†èƒåè°ƒç‚ç—‡å˜åŒ– [scRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jie An ; Rachael Bogle ; Rayan Najjar ; Lam C Tsoi ; Michelle Kahlenberg ; Ksenia Anufrieva ; Erin Theisen ; Kevin Wei ; Johann E Gudjonsson ; Keith E ElkonSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTo elucidate the complex effects of acute UV radiation (UVR) on the skin, we exposed shaved mouse skin to UVB and performed transcriptomic profiling of the epidermis, deep dermis and adipose tissue. Spatial transcriptomic analysis revealed the most pronounced gene expression changes in the epidermis, peaking at 24 hours post-irradiation. While CD45âº immune cells showed differential expression of chemokines, cytokines, and acute-phase proteins, cytokeratinâº epidermal cells upregulated genes related to cellular stress and damage (e.g., Usp19, Adam25), as well as structural remodeling and apoptosis (e.g., Krt18, Phlda1). Single-cell RNA sequencing (scRNA-seq) conducted 12 hours after UVR exposure identified 4,849 differentially expressed genes (DEGs), with the epidermis and endothelial cells showing the highest DEG counts. Pathway analysis of upregulated genes in the epidermis revealed enrichment in VEGF, HIPPO, complement, IL-6, and apoptosis signaling pathways. In endothelial cells, UVR induced expression of multiple chemokines and cytokines. Notably, receptor-ligand analysis highlighted endothelial cells as key targets of CXCL chemokines and complement component C3. In fibroblasts, UVR triggered upregulation of inflammatory activation markers (Osmr, Cux1) alongside genes associated with glucose metabolism (Hif1a, Pkm). Cross-species comparison of UVR-responsive DEGs between mice and humans revealed strong concordance, particularly in TGF-Î² and TNF-associated pathways.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298107" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE309517 æŠ‘åˆ¶ç™Œç—‡å¹²ç»†èƒå…ç–«æ£€æŸ¥ç‚¹ SOAT1 é€šè¿‡è·¨ç»†èƒ 20(S)-ç¾ŸåŸºèƒ†å›ºé†‡-GPR132 é€šè·¯æŠ‘åˆ¶å°é¼ çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€T cellã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Yahui DingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSOAT1 (sterol O-acyltransferase 1) serves as a cancer stem cell-specific immune checkpoint that facilitates trans-cellular signaling through the release of 20-Hydroxycholesterol (20-OHC) and subsequent activation of GPR132 on regulatory T cells (Tregs). This pathway plays a crucial role in modulating the tumor immune microenvironment and can significantly influence the balance between immune activation and suppression. In the context of cancer, SOAT1 is instrumental in regulating the cholesterol metabolism of cancer stem cells. When SOAT1 is inhibited, there is an increase in the secretion of 20-OHC by tumor cells. This oxysterol not only functions as a signaling molecule but also acts as a ligand that binds to GPR132, a G protein-coupled receptor primarily expressed on immune cells, including Tregs. This binding triggers a cascade of intracellular signaling pathways that ultimately enhances the immunosuppressive functions of Tregs. Mechanistically, the activation of GPR132 by 20-OHC leads to downstream signaling events that may involve pathways such as JAK-STAT and PKC signaling, promoting the development and survival of Tregs while enabling them to exert their immunosuppressive effects within the tumor microenvironment. This results in the downregulation of effector T cell activities and impairs the maturation and activation of dendritic cells (DCs), which are pivotal for effective anti-tumor immune responses. The presence of Tregs, particularly in elevated frequencies within tumors, can contribute to an immunosuppressive environment that protects cancer cells from immune-mediated destruction. Thus, the SOAT1-20OHC-GPR132 axis represents a critical mechanism through which cancer cells can evade immune surveillance. By controlling cholesterol metabolism through SOAT1, tumors can manipulate the availability of 20-OHC, amplifying the immunosuppressive capacity of Tregs and facilitating an environment conducive to tumor growth and progression. Targeting SOAT1 and the associated 20-OHC signaling pathway may offer a promising therapeutic strategy to neutralize Treg-mediated immunosuppression. Inhibiting SOAT1 not only disrupts the tumor's ability to produce 20-OHC but also potentially reprograms the immune landscape, promoting a more activated and effective anti-tumor immune response. Overall, SOAT1's dual role as a cancer stem cell-specific immune ch...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309517" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE286092 æŠ‘åˆ¶ç™Œç—‡å¹²ç»†èƒå…ç–«æ£€æŸ¥ç‚¹ SOAT1 é€šè¿‡è·¨ç»†èƒ 20(S)-ç¾ŸåŸºèƒ†å›ºé†‡-GPR132 é€šè·¯æŠ‘åˆ¶å°é¼ çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€T cellã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Yahui DingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSOAT1 (sterol O-acyltransferase 1) serves as a cancer stem cell-specific immune checkpoint that facilitates trans-cellular signaling through the release of 20-Hydroxycholesterol (20-OHC) and subsequent activation of GPR132 on regulatory T cells (Tregs). This pathway plays a crucial role in modulating the tumor immune microenvironment and can significantly influence the balance between immune activation and suppression. In the context of cancer, SOAT1 is instrumental in regulating the cholesterol metabolism of cancer stem cells. When SOAT1 is inhibited, there is an increase in the secretion of 20-OHC by tumor cells. This oxysterol not only functions as a signaling molecule but also acts as a ligand that binds to GPR132, a G protein-coupled receptor primarily expressed on immune cells, including Tregs. This binding triggers a cascade of intracellular signaling pathways that ultimately enhances the immunosuppressive functions of Tregs. Mechanistically, the activation of GPR132 by 20-OHC leads to downstream signaling events that may involve pathways such as JAK-STAT and PKC signaling, promoting the development and survival of Tregs while enabling them to exert their immunosuppressive effects within the tumor microenvironment. This results in the downregulation of effector T cell activities and impairs the maturation and activation of dendritic cells (DCs), which are pivotal for effective anti-tumor immune responses. The presence of Tregs, particularly in elevated frequencies within tumors, can contribute to an immunosuppressive environment that protects cancer cells from immune-mediated destruction. Thus, the SOAT1-20OHC-GPR132 axis represents a critical mechanism through which cancer cells can evade immune surveillance. By controlling cholesterol metabolism through SOAT1, tumors can manipulate the availability of 20-OHC, amplifying the immunosuppressive capacity of Tregs and facilitating an environment conducive to tumor growth and progression. Targeting SOAT1 and the associated 20-OHC signaling pathway may offer a promising therapeutic strategy to neutralize Treg-mediated immunosuppression. Inhibiting SOAT1 not only disrupts the tumor's ability to produce 20-OHC but also potentially reprograms the immune landscape, promoting a more activated and effective anti-tumor immune response. Overall, SOAT1's dual role as a cancer stem cell-specific immune ch...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286092" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE286015 æŠ‘åˆ¶ç™Œç—‡å¹²ç»†èƒå…ç–«æ£€æŸ¥ç‚¹ SOAT1 é€šè¿‡è·¨ç»†èƒ 20(S)-ç¾ŸåŸºèƒ†å›ºé†‡-GPR132 é€šè·¯æŠ‘åˆ¶å°é¼ çš„è°ƒèŠ‚æ€§ T ç»†èƒåŠŸèƒ½ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€T cellã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributor : Yahui DingSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusSOAT1 (sterol O-acyltransferase 1) serves as a cancer stem cell-specific immune checkpoint that facilitates trans-cellular signaling through the release of 20-Hydroxycholesterol (20-OHC) and subsequent activation of GPR132 on regulatory T cells (Tregs). This pathway plays a crucial role in modulating the tumor immune microenvironment and can significantly influence the balance between immune activation and suppression. In the context of cancer, SOAT1 is instrumental in regulating the cholesterol metabolism of cancer stem cells. When SOAT1 is inhibited, there is an increase in the secretion of 20-OHC by tumor cells. This oxysterol not only functions as a signaling molecule but also acts as a ligand that binds to GPR132, a G protein-coupled receptor primarily expressed on immune cells, including Tregs. This binding triggers a cascade of intracellular signaling pathways that ultimately enhances the immunosuppressive functions of Tregs. Mechanistically, the activation of GPR132 by 20-OHC leads to downstream signaling events that may involve pathways such as JAK-STAT and PKC signaling, promoting the development and survival of Tregs while enabling them to exert their immunosuppressive effects within the tumor microenvironment. This results in the downregulation of effector T cell activities and impairs the maturation and activation of dendritic cells (DCs), which are pivotal for effective anti-tumor immune responses. The presence of Tregs, particularly in elevated frequencies within tumors, can contribute to an immunosuppressive environment that protects cancer cells from immune-mediated destruction. Thus, the SOAT1-20OHC-GPR132 axis represents a critical mechanism through which cancer cells can evade immune surveillance. By controlling cholesterol metabolism through SOAT1, tumors can manipulate the availability of 20-OHC, amplifying the immunosuppressive capacity of Tregs and facilitating an environment conducive to tumor growth and progression. Targeting SOAT1 and the associated 20-OHC signaling pathway may offer a promising therapeutic strategy to neutralize Treg-mediated immunosuppression. Inhibiting SOAT1 not only disrupts the tumor's ability to produce 20-OHC but also potentially reprograms the immune landscape, promoting a more activated and effective anti-tumor immune response. Overall, SOAT1's dual role as a cancer stem cell-specific immune ch...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286015" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE298108 å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºç´«å¤–çº¿ç…§å°„åè¡€ç®¡ç»†èƒå¯¹ç‚ç—‡å˜åŒ–çš„è°ƒæ§ä½œç”¨ [ç©ºé—´è½¬å½•ç»„å­¦]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jie An ; Rachael Bogle ; Rayan Najjar ; Lam C Tsoi ; Michelle Kahlenberg ; Ksenia Anufrieva ; Erin Theisen ; Kevin Wei ; Johann E Gudjonsson ; Keith E ElkonSeries Type : OtherOrganism : Mus musculusTo elucidate the complex effects of acute UV radiation (UVR) on the skin, we exposed shaved mouse skin to UVB and performed transcriptomic profiling of the epidermis, deep dermis and adipose tissue. Spatial transcriptomic analysis revealed the most pronounced gene expression changes in the epidermis, peaking at 24 hours post-irradiation. While CD45âº immune cells showed differential expression of chemokines, cytokines, and acute-phase proteins, cytokeratinâº epidermal cells upregulated genes related to cellular stress and damage (e.g., Usp19, Adam25), as well as structural remodeling and apoptosis (e.g., Krt18, Phlda1). Single-cell RNA sequencing (scRNA-seq) conducted 12 hours after UVR exposure identified 4,849 differentially expressed genes (DEGs), with the epidermis and endothelial cells showing the highest DEG counts. Pathway analysis of upregulated genes in the epidermis revealed enrichment in VEGF, HIPPO, complement, IL-6, and apoptosis signaling pathways. In endothelial cells, UVR induced expression of multiple chemokines and cytokines. Notably, receptor-ligand analysis highlighted endothelial cells as key targets of CXCL chemokines and complement component C3. In fibroblasts, UVR triggered upregulation of inflammatory activation markers (Osmr, Cux1) alongside genes associated with glucose metabolism (Hif1a, Pkm). Cross-species comparison of UVR-responsive DEGs between mice and humans revealed strong concordance, particularly in TGF-Î² and TNF-associated pathways.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298108" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE298654 åˆ©ç”¨åŒå…‰å­æ¿€å‘è§å…‰ï¼ˆTPEFï¼‰ã€è´¨è°±å’ŒRNAæµ‹åºåˆ†æç ”ç©¶ç™Œç—‡æ²»ç–—è¯±å¯¼è¡°è€ç»†èƒçš„ä»£è°¢ç‰¹å¾</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€metabolicã€sequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Silvia Ghislanzoni ; Federica Padelli ; Alessia Bertolotti ; Antonino Belfiore ; Matteo Niero ; Arianna Bresci ; Silvia Betti ; Andrea Masella ; Dario Polli ; Luca Agnelli ; Italia BongarzoneSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensBackground. Despite major advances in cancer therapies, treatment failure remains a significant issue for a subset of patients due to therapy resistance and tumour recurrence. A key contributor to these failures is therapy-induced senescence, wherein damaged cells enter a stable cell cycle arrest while remaining metabolically active, contributing to chronic inflammation and cancer relapse. These senescent cells can promote chronic inflammation and disease relapse. However, the heterogeneous nature of senescence complicates its detection and therapeutic targeting. Methods. We employed a multimodal approach to profile metabolic alterations in senescent cancer cells. Senescent cells were induced either by doxorubicin or Î³-irradiation, both widely employed strategies in anti-cancer treatment, across three human cancer cell lines: MCF7, HeLa, and TPC-1. Mitochondrial dysfunction was assessed through MitoTracker and JC-1 staining. Two-photon excitation fluorescence microscopy enabled label-free imaging of mitochondrial coenzymes NAD(P)H and FAD. Lipidomic changes were analyzed using MALDI mass spectrometry imaging following lipid extraction and matrix application. Additionally, transcriptomic profiling via RNA sequencing was performed on control, senescent, and engulfing-senescent MCF7 cells. Bioinformatic analyses included differential gene expression, gene set enrichment analysis, and pathway analysis using GO, KEGG, and Reactome databases Results. Across all models, senescent cells exhibited mitochondrial dysfunction, marked by altered NAD(P)H and FAD distribution and decreased mitochondrial membrane potential. Two-photon excited fluorescence imaging confirmed a broader intracellular redistribution of mitochondrial coenzymes. MALDI analyses revealed consistent lipid remodeling, particularly involving cardiolipin precursors such as PG(18:1/18:1) and PG(18:1/22:6). Transcriptomic profiling of senescent MCF7 cells revealed that a previously observed engulfing subpopulation is marked by enhanced oxidative metabolism and increased lipid catabolism, suggestive of an engulfing phenotype. Conclusion. Our findings delineate both conserved and divergent metabolic features across se...<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298654" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> <strong>GSE306669 Kar4 åœ¨é…¿é…’é…µæ¯ä¸­ä½œä¸º Ste12 è°ƒèŠ‚å› å­ï¼Œä¿ƒè¿› Ste12 ä¸åŸºå› ç»„èŒƒå›´å†…çš„ç‰¹å®š DNA åŸºåºç»“åˆ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seqã€genome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jason Rogers ; Amanda Yeo ; Val Meleshkevich ; Hernan Lorenzi ; Mark Rose ; Orna Cohen-FixSeries Type : Expression profiling by high throughput sequencingOrganism : Saccharomyces cerevisiaeKar4 is a putative transcription factor essential for mating in the budding yeast Saccharomyces cerevisiae. Kar4 has been shown to function with Ste12, the master transcriptional regulator of the yeast mating pheromone response, to promote the transcription of a subset of Ste12 targets required for efficient mating. However, the mechanism by which Kar4 modulates Ste12 activity has remained uncertain. Here, we examine the effect of Kar4 on the mating pheromone response at the levels of transcription (RNA-seq)<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306669" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> <strong>GSE245713 åˆ©ç”¨å•ç»†èƒå¤šç»„å­¦æ–¹æ³•å¯¹æœ€æ—©çš„å¿ƒè„è°±ç³»åˆ†ç¦»è¿›è¡Œè¡¨è§‚é—ä¼ å­¦åˆ»ç”»</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€epigenetic<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245713" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> <strong>GSE245709 å°é¼ èƒšèƒå¹²ç»†èƒå®šå‘å¿ƒè„åˆ†åŒ–ä¸åŒé˜¶æ®µ Hand1 å’Œ Foxf1 çš„ ChIP-seq åˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€ChIP-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jingjing He ; Chengqi LinSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusChIP-seq data for candidates identified from targeted screen for cardiac differentiation<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE245709" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> <strong>GSE290059 æœè‡èƒ¶è´¨ç˜¤æ¨¡å‹ä¸­ Ca-Î±1T å’Œ Slo æ•²ä½çš„ RNA-seq</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgliomaã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : LÃ­a Alza ; Judit Herreros ; Carles CantÃ­ ; Sergio Casas ; Andreu CasaliSeries Type : Expression profiling by high throughput sequencingOrganism : Drosophila melanogasterThis dataset presents transcriptomic profiles of Drosophila melanogaster glioma model to investigate the effects of Ca-Î±1T and Slo knockdowns on gene expression. The samples consist of dissected Drosophila heads. The glioma model used were based on the study by Read et al., 2009 (PLOS Genetics), which established a Drosophila model of glioma by co-overexpressing an activated form of dEGFR (dEGFRÎ») and dp110 (dp110CAAX) in glial cells (Read et al., 2009). This work was supported by the research project 'Programa GeneraciÃ³n de Conocimiento PID2022-138688OB-I00' funded by the Spanish Ministry of Science and Innovation.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290059" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 41 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ”¬ æœŸåˆŠæ–‡ç«  (4æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨4æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>Vebreltinib åœ¨ MET æ‰©å¢é©±åŠ¨çš„æ™šæœŸéå°ç»†èƒè‚ºç™Œï¼ˆKUNPENGï¼‰ï¼šä¸€é¡¹å•è‡‚ã€å¤šé˜Ÿåˆ—ã€å¤šä¸­å¿ƒã€äºŒæœŸä¸´åºŠç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šTç»†èƒã€Bç»†èƒ<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998008756811268096/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>2020å¹´è‡³2023å¹´ç¾å›½åŠ³åŠ¨å¹´é¾„æˆå¹´äººæŒ‰å…·ä½“èŒä¸šåˆ’åˆ†çš„ç™Œç—‡æ­»äº¡ç‡ï¼šåŸºäºäººå£çš„ç ”ç©¶</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: èƒŒæ™¯å°½ç®¡é«˜æ”¶å…¥å›½å®¶æ•´ä½“ä¸‹é™ï¼Œä½†æŸäº›ç™Œç—‡ç±»å‹çš„æ­»äº¡ç‡åœ¨å·¥ä½œå¹´é¾„æˆå¹´äººä¸­ä»åœ¨ä¸Šå‡ã€‚æœ¬ç ”ç©¶æ—¨åœ¨æ ¹æ®æ€§åˆ«ã€ç™Œç—‡ç±»å‹å’Œå…·ä½“èŒä¸šåœ¨ç¾å›½å·¥ä½œå¹´é¾„æˆå¹´äººä¸­ç»Ÿè®¡ç™Œç—‡æ­»äº¡ç‡ã€‚æ–¹æ³•2020 å¹´è‡³ 2023 å¹´é—´ï¼Œ20 è‡³ 64 å²æˆå¹´äººçš„ç™Œç—‡æ­»äº¡äººæ•°ï¼ˆICD-10 ä»£ç  C00â€“C99ï¼‰æ•°æ®æ¥æºäºç¾å›½å›½å®¶å¥åº·ç»Ÿè®¡ä¸­å¿ƒå’Œå›½å®¶ç”Ÿå‘½ç»Ÿè®¡ç³»ç»Ÿæä¾›çš„æ­»äº¡å¤šå› æ­»äº¡æ•°æ®ï¼Œå¹¶æŒ‰æ€§åˆ«ã€èŒä¸šã€å¹´é¾„å’Œå¹´ä»½åˆ†ç±»ï¼Œä½¿ç”¨äº† 459 ä¸ªè¯¦ç»†çš„ 2010 å¹´ç¾å›½äººå£æ™®æŸ¥èŒä¸šä»£ç å’Œ 23 ä¸ªä¸»è¦èŒä¸šç¾¤ä½“ã€‚æŒ‰æ€§åˆ«ã€å¹´é¾„ã€å¹´ä»½å’ŒèŒä¸šä¼°è®¡çš„äººå£æ•°æ®æ¥è‡ªå¹´åº¦ç¾å›½ç¤¾åŒºè°ƒæŸ¥å’Œåå¹´ä¸€æ¬¡äººå£æ™®æŸ¥ã€‚æŒ‰æ€§åˆ«ã€èŒä¸šå’Œ 22 ä¸ªä¸»è¦ç™Œç—‡éƒ¨ä½åˆ’åˆ†çš„å¹´å¹³å‡ç™Œç—‡æ­»äº¡ç‡å’Œ 95%ç½®ä¿¡åŒºé—´ï¼ˆCIï¼‰è¢«ç»Ÿè®¡å¹¶å±•ç¤ºåœ¨æ£®æ—åœ°å—ä¸­ã€‚å‘ç°è¯¥ç ”ç©¶äº2022å¹´3æœˆ15æ—¥è‡³2025å¹´8æœˆ27æ—¥è¿›è¡Œã€‚åœ¨450,453ä¾‹ç™Œç—‡æ­»äº¡ä¸­ï¼Œæ¯10ä¸‡ç¾å›½å·¥ä½œå¹´é¾„å±…æ°‘çš„å¹³å‡å¹´é¾„è°ƒæ•´ç™Œç—‡æ­»äº¡ç‡ä¸ºç”·æ€§55.2ï¼ˆ95%ç½®ä¿¡åŒºé—´54<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998021646852018176/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>é¢„é˜²èŒä¸šæ€§ç™Œç—‡çš„é‡è¦æ€§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šç™Œç—‡<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext:<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998005671955202048/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>çš®æ‰˜å¸ƒæ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼åœ¨æ²»ç–—ä¸­â€”â€”åˆæ¬¡åŠå¤å‘/éš¾æ²»æ€§æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šæ·‹å·´<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSecret hovertext: ç›®çš„ å¡å¸ƒæ›¿å°¼æ˜¯ä¸€ç§é«˜åº¦é€‰æ‹©æ€§çš„éå…±ä»·å¸ƒé²é¡¿é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚ï¼ˆBTKiï¼‰ï¼Œåœ¨æ¥å—è¿‡å…±ä»· BTKi çš„æ…¢æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…/å°æ·‹å·´ç»†èƒæ·‹å·´ç˜¤ï¼ˆCLL/SLLï¼‰æ‚£è€…ä¸­å·²æ˜¾ç¤ºå‡ºç–—æ•ˆå’Œå®‰å…¨æ€§ã€‚æ®æˆ‘ä»¬æ‰€çŸ¥ï¼Œæˆ‘ä»¬æŠ¥å‘Šäº†é¦–æ¬¡éšæœºå¯¹æ¯”å¡æ‰˜å¸ƒé²æ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼åœ¨ BTKi æœªæ²»ç–— CLL/SLL æ‚£è€…ä¸­ï¼Œæ—¢æœ‰æ²»ç–—ç»éªŒï¼ˆTNï¼‰æ‚£è€…ï¼Œä¹ŸåŒ…æ‹¬å¤å‘/éš¾æ²»æ€§ï¼ˆR/Rï¼‰æ‚£è€…çš„ç»“æœã€‚æ‚£è€…ä¸æ–¹æ³• æ‚£è€…ï¼ˆN=662ï¼‰è¢«éšæœº 1ï¼š1 åˆ†é…æ¥å—å¡å¸ƒé²æ›¿å°¼æˆ–ä¼Šå¸ƒæ›¿å°¼ã€‚æ‰€æœ‰æ‚£è€…å¯¹ BTKi éƒ½éå¸¸é™Œç”Ÿã€‚ä¸»è¦ç»ˆç‚¹ä¸ºç‹¬ç«‹è¯„å®¡å§”å‘˜ä¼šï¼ˆIRCï¼‰å¯¹æ‰€æœ‰éšæœºåˆ†é…æ‚£è€…ï¼ˆæ²»ç–—æ„å‘[ITT]ï¼‰åŠ R/R ç—…æ‚£è€…çš„æ€»ä½“ååº”ç‡ï¼ˆORRï¼‰ã€‚ç»“æœ ç ”ç©¶è¾¾åˆ°ä¸»è¦ç»ˆç‚¹ï¼Œè¯æ˜ IRC-ORR åœ¨ ITT ä¸­å¯¹å¡å¸ƒé²æ›¿å°¼ä¸ä¼Šå¸ƒæ›¿å°¼çš„éåŠ£åŠ¿æ€§ï¼ˆNIï¼‰å‡å…·æœ‰ç»Ÿè®¡å­¦æ˜¾è‘—æ€§ï¼ˆNIï¼‰ï¼ˆ87.0% [95% CIï¼Œ82.9 è‡³ 90.4]å¯¹ 78.5% [95% CIï¼Œ73.7 è‡³<br />
- ğŸ”— <a href="https://m.x-mol.com/paper/1998145099328376832/t" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ“Š å­¦ç‚¹ç”Ÿä¿¡ (1æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>Posit Cloud ä¸Šçš„ freeCount ç”Ÿç‰©ä¿¡æ¯å­¦åˆ†æåº”ç”¨ç¨‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šbioinformatics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šOne way that you can use the freeCount R Shiny applications (apps) online is through Posit Cloud, which lets you access powerful data science tools in your browser without the need for installation or complex configuration. Continue reading: freeCount Bioinformatics Analysis Apps on Posit Cloud<br />
- ğŸ”— <a href="https://www.r-bloggers.com/2025/12/freecount-bioinformatics-analysis-apps-on-posit-cloud/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> <strong>è‚ é“åˆ†å­å±•ç°å‡ºæ˜¾è‘—çš„æŠ—ç³–å°¿ç—…èƒ½åŠ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers revealed that the microbial metabolite TMA can directly block the immune protein IRAK4, reducing inflammation and improving insulin sensitivity. The molecule counteracts damage caused by high-fat diets and even protects mice from sepsis. Since IRAK4 is a known drug target, this pathway could inspire new diabetes therapies. The study highlights how gut microbes and nutrition can work together to support metabolic health.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251208052518.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>Isoformicâ€”â€”ä¸€ç§ç”¨äºè½¬å½•æœ¬æ°´å¹³RNAæµ‹åºç»“æœè§£è¯»çš„å·¥ä½œæµç¨‹</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šRNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šIsoformic improves transcript level interpretation of RNA sequencing data, revealing biologically meaningful variants linked to regulatory events and phenotypes...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/isoformic-a-workflow-for-transcript-level-rna-seq-interpretation/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>D3Imputeâ€”â€”é’ˆå¯¹å•ç»†èƒRNAæµ‹åºæ•°æ®çš„dropoutæ„ŸçŸ¥åˆ¤åˆ«ã€åˆ†å¸ƒæ„ŸçŸ¥å»ºæ¨¡å’Œå¯†åº¦å¼•å¯¼æ’è¡¥</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šD3Impute improves single cell RNA sequencing analysis by distinguishing technical zeros from true biological signals and enhancing accuracy...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/d3impute-dropout-aware-discrimination-distribution-aware-modeling-and-density-guide-imputation-for-scrna-seq-data/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>RNA-seq</td>
<td>12</td>
</tr>
<tr>
<td>cancer</td>
<td>10</td>
</tr>
<tr>
<td>sequencing</td>
<td>4</td>
</tr>
<tr>
<td>immune</td>
<td>4</td>
</tr>
<tr>
<td>aging</td>
<td>4</td>
</tr>
<tr>
<td>pathway</td>
<td>4</td>
</tr>
<tr>
<td>scRNA</td>
<td>3</td>
</tr>
<tr>
<td>genome</td>
<td>3</td>
</tr>
<tr>
<td>spatial</td>
<td>3</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>3</td>
</tr>
<tr>
<td>T cell</td>
<td>3</td>
</tr>
<tr>
<td>antigen</td>
<td>3</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>2</td>
</tr>
<tr>
<td>leukemia</td>
<td>2</td>
</tr>
<tr>
<td>cardiac</td>
<td>2</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>2</td>
</tr>
<tr>
<td>RNAseq</td>
<td>2</td>
</tr>
<tr>
<td>transcriptome</td>
<td>2</td>
</tr>
<tr>
<td>ç™Œç—‡</td>
<td>2</td>
</tr>
<tr>
<td>ATAC-seq</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (41æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271390" target="_blank" rel="noopener noreferrer">GSE271390 å·´é›·ç‰¹é£Ÿç®¡å’Œé£Ÿç®¡ç™Œçš„æ— ç»†èƒè½¬å½•ç»„ [Illumina - çŸ­è¯»é•¿]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271389" target="_blank" rel="noopener noreferrer">GSE271389 å·´é›·ç‰¹é£Ÿç®¡å’Œé£Ÿç®¡ç™Œçš„æ— ç»†èƒè½¬å½•ç»„ [çº³ç±³å­”é•¿è¯»é•¿æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306827" target="_blank" rel="noopener noreferrer">GSE306827 å·¨å™¬ç»†èƒä¸“é—¨è´Ÿè´£å‘ MAIT ç»†èƒå‘ˆé€’ MR1 æŠ—åŸ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306826" target="_blank" rel="noopener noreferrer">GSE306826 å·¨å™¬ç»†èƒä¸“é—¨è´Ÿè´£å‘ MAIT ç»†èƒå‘ˆé€’ MR1 æŠ—åŸ [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312514" target="_blank" rel="noopener noreferrer">GSE312514 æ€¥æ€§å»ç¥ç»æ”¯é…çš„è‚Œè‚‰ç»†èƒå¤–å›Šæ³¡é€šè¿‡é€†è¡Œä¿¡å·ä¼ å¯¼é‡å¡‘ç¥ç»å…ƒçº¿ç²’ä½“ä»£è°¢ï¼Œä»è€ŒæŒ½æ•‘å‘¨å›´ç¥ç»æŸä¼¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311088" target="_blank" rel="noopener noreferrer">GSE311088 CDK4é©±åŠ¨çš„é…®ä½“ç”Ÿæˆé‡å¡‘ç»„è›‹ç™½ä¿®é¥°ä»¥ä¿ƒè¿›ç™½è¡€ç—…</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303070" target="_blank" rel="noopener noreferrer">GSE303070 ç»“ç›´è‚ ç™Œç©ºé—´å›¾è°±æ­ç¤ºäº†åŸºè´¨å¾®ç¯å¢ƒå¯¹è‚¿ç˜¤åˆ†åŒ–çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE270919" target="_blank" rel="noopener noreferrer">GSE270919 CDK4 å¯¹ç»„è›‹ç™½ä¿®é¥°çš„ç”Ÿé…®è°ƒæ§ä¿ƒè¿›ç™½è¡€ç—…å‘ç”Ÿ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE253660" target="_blank" rel="noopener noreferrer">GSE253660 ç¾Ÿé…°è¾…é…¶Aè„±æ°¢é…¶çš„ä¸€ç§æ ¸åŒå·¥é…¶æŠ‘åˆ¶ç»“ç›´è‚ ç™Œçš„è‚¿ç˜¤è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309755" target="_blank" rel="noopener noreferrer">GSE309755 äººç±»è„‘ç±»å™¨å®˜ RNA æµ‹åºï¼Œç”¨äºè¯„ä¼°æ€§åˆ«ç‰¹å¼‚æ€§å’Œå…‰ FGFR ä»‹å¯¼çš„å¯¹ç®€åŒ– 5 ç¦»å­ GCR æ¨¡æ‹Ÿçš„ååº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309036" target="_blank" rel="noopener noreferrer">GSE309036 é˜¿å°”èŒ¨æµ·é»˜ç—…æ‚£è€…é¢å¶çš®å±‚ä¸­å·®å¼‚è¡¨è¾¾çš„ miRNA åŠå…¶ä¸ tau ç—…ç†çš„å…³ç³»ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306791" target="_blank" rel="noopener noreferrer">GSE306791 Kar4 åœ¨é…¿é…’é…µæ¯ä¸­ä½œä¸º Ste12 çš„è°ƒèŠ‚å› å­ï¼Œä¿ƒè¿› Ste12 ä¸åŸºå› ç»„èŒƒå›´å†…çš„ç‰¹å®š DNA åŸºåºç»“åˆã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306667" target="_blank" rel="noopener noreferrer">GSE306667 Kar4 åœ¨é…¿é…’é…µæ¯ä¸­ä½œä¸º Ste12 è°ƒèŠ‚å› å­ï¼Œä¿ƒè¿› Ste12 ä¸åŸºå› ç»„èŒƒå›´å†…çš„ç‰¹å®š DNA åŸºåºç»“åˆ [ChIP-exo]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305266" target="_blank" rel="noopener noreferrer">GSE305266 çš®è´¨å¾®ç¯å¢ƒé©±åŠ¨æ—©æœŸå…ç–«ç»„ç»‡å¹¶æ§åˆ¶éª¨æ„ˆåˆè¿‡ç¨‹ä¸­çš„æ—©æœŸç ´éª¨ç»†èƒç”Ÿæˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292865" target="_blank" rel="noopener noreferrer">GSE292865 ELOVL5 ä¿ƒè¿› T ç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…çš„è¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288604" target="_blank" rel="noopener noreferrer">GSE288604 å…¨è¡€è½¬å½•ç»„å­¦è¡¨å¾è‚ºéƒ¨é¸Ÿåˆ†ææ†èŒå¤åˆç¾¤ç–¾ç—…çš„åˆ†å­è¡¨å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285936" target="_blank" rel="noopener noreferrer">GSE285936 å•æ ¸ RNA æµ‹åºæ­ç¤ºäº†æ­»åé—´éš”å¯¹å°é¼ è„‘ç»†èƒæˆåˆ†å’ŒåŸºå› è¡¨è¾¾åˆ†æçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312906" target="_blank" rel="noopener noreferrer">GSE312906ï¼šé‰´å®šå¯¹é›Œæ¿€ç´ å—ä½“Î±ç»“åˆåŠå…¶å¯¹å­å®«å†…è†œç™ŒåŸºå› è¡¨è¾¾çš„å½±å“å…·æœ‰ç‹¬ç‰¹å½±å“çš„åŸºå› ç»„ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305933" target="_blank" rel="noopener noreferrer">GSE305933 äººç±»èƒšèƒå¹²ç»†èƒè¡ç”Ÿå¤šæ¿€ç´ ç»†èƒåˆ†åŒ–è¿‡ç¨‹ä¸­çš„æ—¶é—´å¤šç»„å­¦åŸºå› è¡¨è¾¾æ•°æ® [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298408" target="_blank" rel="noopener noreferrer">GSE298408 é“¶å±‘ç—…æœŸé—´çš®è‚¤æ„Ÿè§‰ç¥ç»å…ƒçš„å•æ ¸RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271259" target="_blank" rel="noopener noreferrer">GSE271259 äººç±»åŸå‘æ€§è‚ºè…ºç™Œå’Œè„‘è½¬ç§»çš„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311624" target="_blank" rel="noopener noreferrer">GSE311624 å•æ ¸ RNA æµ‹åºæ­ç¤ºäº† LPD å–‚å…»çš„å°é¼ ä¸­è¡¨è¾¾ c-Met/Î²-catenin ç™ŒåŸºå› çš„é‡ç¼–ç¨‹è‚ç»†èƒã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311027" target="_blank" rel="noopener noreferrer">GSE311027 æ…¢æ€§ç¤¾ä¼šæŒ«è´¥åº”æ¿€åå°é¼ å‰é¢å¶çš®å±‚çš„ H3K4me3 ChIP-seq åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310077" target="_blank" rel="noopener noreferrer">GSE310077 é€šè¿‡SB-HTVIå¯¹æ³¨å°„è½½ä½“å¯¹ç…§æˆ–c-Met/Î”N90-Î²-cateninçš„CDå’ŒLPDå–‚å…»å°é¼ è¿›è¡Œæ‰¹é‡RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310076" target="_blank" rel="noopener noreferrer">ä½¿ç”¨è½½ä½“å¯¹ç…§ç»„è‚è„å’Œæ¥å— c-Met/Î”N90-Î²-catenin SB-HTVI å¤„ç† 2 å‘¨å’Œ 3 å‘¨çš„è‚è„ï¼Œå¯¹ GSE310076 è‚è„ç»„ç»‡è¿›è¡Œäº†æ‰¹é‡ RNA æµ‹åºã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309980" target="_blank" rel="noopener noreferrer">GSE309980 äººç±»è¡°è€å¾®ç”Ÿç†ç³»ç»Ÿé‡ç°ä½“å†…è¿‡ç¨‹ï¼ŒåŠ é€ŸæŠ—è¡°è€ç­–ç•¥çš„è¯„ä¼°</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297347" target="_blank" rel="noopener noreferrer">GSE297347 DLX2-LAP2Î± è½´é€šè¿‡è§£é”æŸ“è‰²è´¨å±éšœæ¥ä¿ƒè¿›é¢…é¢å†ç”Ÿï¼Œä»è€Œæ¿€æ´»å¤–èƒšå±‚é—´å……è´¨åˆ†åŒ– [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297346" target="_blank" rel="noopener noreferrer">GSE297346 DLX2-LAP2Î± è½´é€šè¿‡è§£é”æŸ“è‰²è´¨å±éšœæ¥ä¿ƒè¿›é¢…é¢å†ç”Ÿï¼Œä»è€Œæ§åˆ¶å¤–èƒšå±‚é—´å……è´¨çš„åˆ†åŒ– [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295479" target="_blank" rel="noopener noreferrer">GSE295479 Drp1 é€šè¿‡ Erk1/2-Nur77 é€šè·¯è°ƒèŠ‚çº¿ç²’ä½“å¥åº·å¹¶æ§åˆ¶éª¨éª¼è‚Œè´¨é‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280361" target="_blank" rel="noopener noreferrer">GSE280361 äººç±»è¡°è€å¾®ç”Ÿç†ç³»ç»Ÿé‡ç°ä½“å†…è¿‡ç¨‹ï¼ŒåŠ é€ŸæŠ—è¡°è€ç­–ç•¥çš„è¯„ä¼°</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312581" target="_blank" rel="noopener noreferrer">GSE312581 æ–°å‹ SLCO2B1 mRNA äºšå‹ä½œä¸ºéç¼–ç  RNAï¼Œé€šè¿‡ FMR1 ä»‹å¯¼çš„è›‹ç™½è´¨ç”Ÿç‰©åˆæˆé©±åŠ¨ç™Œç—‡è¿›å±•ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312333" target="_blank" rel="noopener noreferrer">GSE312333 BHBå¯¹æŠ—åŸåˆºæ¿€çš„CART19ç»†èƒè½¬å½•å˜åŒ–çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312324" target="_blank" rel="noopener noreferrer">GSE312324 RNAæµ‹åºåˆ†æï¼šé‡ç”Ÿå‹ã€Lao1åŸºå› æ•²é™¤å°é¼ å’ŒLao1/Il4i1åŒåŸºå› æ•²é™¤å°é¼ åœ¨æ­£å¸¸å’ŒDSSå¤„ç†æ¡ä»¶ä¸‹çš„RNAæµ‹åºç»“æœ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311939" target="_blank" rel="noopener noreferrer">GSE311939 MTFP1å‚ä¸ç‰›åµæ¯ç»†èƒæˆç†Ÿçš„æœºåˆ¶[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311221" target="_blank" rel="noopener noreferrer">GSE311221 äººç±»é€ è¡€çš„åˆ†å­å’Œè¡¨å‹è“å›¾å°†å¢æ®–åº”æ¿€ä¸å¹²ç»†èƒè¡°è€è”ç³»èµ·æ¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283869" target="_blank" rel="noopener noreferrer">GSE283869 è›‹ç™½æ¿€é…¶Aé€šè¿‡ALKBH5çš„ç£·é…¸åŒ–æ§åˆ¶GPX4 m6Aä¿®é¥°æ¥è°ƒèŠ‚é“æ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261606" target="_blank" rel="noopener noreferrer">GSE261606 Xistéç¼–ç RNAç›´æ¥è°ƒæ§XæŸ“è‰²ä½“å¤±æ´»çš„é€ƒé€¸[Capture Hi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE260483" target="_blank" rel="noopener noreferrer">GSE260483 X å¤±æ´»é€ƒé€¸å— Xist éç¼–ç  RNA [ç”²åŸºåŒ–] ç›´æ¥è°ƒæ§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259399" target="_blank" rel="noopener noreferrer">GSE259399 Xistéç¼–ç RNAç›´æ¥è°ƒæ§XæŸ“è‰²ä½“å¤±æ´»çš„é€ƒé€¸[ç»†èƒç³»RNAæµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE259398" target="_blank" rel="noopener noreferrer">GSE259398 Xistéç¼–ç RNAç›´æ¥è°ƒæ§XæŸ“è‰²ä½“å¤±æ´»çš„é€ƒé€¸[ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE243327" target="_blank" rel="noopener noreferrer">GSE243327 äººç±»é€ è¡€çš„åˆ†å­å’Œè¡¨å‹è“å›¾å°†å¢æ®–åº”æ¿€ä¸å¹²ç»†èƒè¡°è€è”ç³»èµ·æ¥</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-09 21:37</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>